Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on American Business Times.
Press releases published on May 31, 2025
She Who Earns the Rose May Bear It: Sweet Briar Graduates 104 Seniors During 116th Commencement Ceremony
EIN Presswire
·
May 31, 2025
Sweet Briar celebrates the Class of 2025 and their achievements during the College’s 116th Commencement, honoring 104 graduates from 22 states and 13 countries. SWEET BRIAR, VA, UNITED STATES, May 31, 2025 /EINPresswire.com/ -- There’s never a happier …
PlanChecker AI Launches with the Goal to Rewire the Infrastructure of Real Estate Development
EIN Presswire
·
May 31, 2025
LOS ANGELES, CA, UNITED STATES, May 31, 2025 /EINPresswire.com/ -- Co-founded by veteran real estate developer Matthew Raanan and senior software engineer Justine Raanan, the Los Angeles-based startup PlanCheker AI launches as an innovative compliance …
Robex gibt Abschluss des Börsengangs bekannt
GlobeNewswire
·
May 31, 2025
STADT QUÉBEC, May 31, 2025 (GLOBE NEWSWIRE) -- Der westafrikanische Goldproduzent und -erschließer Robex Resources Inc („Robex“ oder das „Unternehmen“) (TSX-V: RBX) freut sich bekannt zu geben, dass das Unternehmen den Börsengang an der Australian …
Robex annonce la finalisation de son introduction en bourse
GlobeNewswire
·
May 31, 2025
QUÉBEC, 31 mai 2025 (GLOBE NEWSWIRE) -- Robex Resources Inc. (« Robex » ou la « Société ») (TSX-V : RBX), producteur et développeur aurifère ouest-africain, a le plaisir d’annoncer le succès de son introduction sur la bourse australienne (« ASX ») avec 38 …
ThinkCareBelieve: Week 19 of President Trump’s American Leadership
GlobeNewswire
·
May 31, 2025
Washington, DC, May 31, 2025 (GLOBE NEWSWIRE) -- Link to ThinkCareBelieve's Article: https://thinkcarebelieve.blog/2025/05/31/week-19-of-president-trumps-american-leadership/ ThinkCareBelieve has published an article on America's 19th week under the …
Arvinas and Pfizer's Vepdegestrant Significantly Improves Progression-Free Survival for Patients with ESR1-Mutant, ER+/HER2- Advanced Breast Cancer
GlobeNewswire
·
May 31, 2025
Pivotal Phase 3 VERITAC-2 clinical trial results presented at ASCO demonstrate 2.9-month improvement in median progression-free survival when compared to fulvestrant in second line-plus patients with an estrogen receptor 1 mutation Vepdegestrant was …
Lancaster Resources Announces Closing Conditions Met for Lake Cargelligo Acquisition
GlobeNewswire
·
May 31, 2025
VANCOUVER, British Columbia, May 30, 2025 (GLOBE NEWSWIRE) -- Lancaster Resources Inc. (CSE:LCR) (OTC Pink:LANRF) (FRA:6UF0) (“Lancaster”), is pleased to announce it has received approval from the Canadian Securities Exchange to complete the acquisition of …